Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CGEM
Stock Latest News
Ratings
Promising Developments in Cullinan Management’s Cancer Treatment Pipeline Drive Buy Rating
3d ago
CGEM
Premium
The Fly
Cullinan Therapeutics assumed with a Buy at H.C. Wainwright
3d ago
CGEM
Premium
The Fly
Cullinan has positive read from Novartis data, says Clear Street
12d ago
NVS
CGEM
Premium
Ratings
Promising Pipeline Developments and Strategic Collaborations Drive Buy Rating for Cullinan Management
15d ago
CGEM
Premium
Company Announcements
Cullinan Management’s Transition to Smaller Reporting Status: Balancing Reduced Disclosures and Investor Concerns
16d ago
CGEM
Premium
Company Announcements
Cullinan Therapeutics Reports Q2 2025 Financial Results
16d ago
CGEM
Premium
Ratings
Cullinan Management: Strong Financials and Promising Pipeline Justify Buy Rating
16d ago
CGEM
Premium
Company Announcements
Cullinan Management Appoints New Board Members
17d ago
8K
CGEM
Premium
The Fly
Cullinan Therapeutics reports Q2 EPS ($1.07), consensus (86c)
17d ago
CGEM
Premium
The Fly
Cullinan Therapeutics management to meet virtually with Clear Street
25d ago
CGEM
Premium
The Fly
Disc Medicine appoints Ahmed to its Board of Directors
1M ago
CGEM
IRON
Premium
Company Announcements
Cullinan Management Holds Annual Stockholders Meeting
2M ago
8K
CGEM
Premium
The Fly
Cullinan Therapeutics resumed with a Buy at Stifel
2M ago
CGEM
Premium
Ratings
Cullinan Management’s Strategic Expansion and Promising Velinotamig Results Justify Buy Rating
3M ago
CGEM
Premium
Ratings
Cullinan Management’s Strategic Growth and Pipeline Expansion Earns Buy Rating
3M ago
CGEM
Premium
Ratings
Cullinan Management: Strategic Licensing and Financial Stability Drive Buy Rating
3M ago
CGEM
Premium
Company Announcements
Cullinan Management Enters Global License Agreement with Genrix
3M ago
8K
CGEM
Premium
The Fly
Cullinan licenses rights to velinotamig from Genrix Bio for $20M upfront
3M ago
CGEM
Premium
Ratings
Cullinan Management’s Promising Position in Healthcare: Buy Rating Supported by Strong Phase 2b Data and Strategic Developments
3M ago
CGEM
Premium
Ratings
Promising Potential of Zipalertinib Drives Buy Rating for Cullinan Management
3M ago
CGEM
Premium
Ratings
Positive Outlook for Cullinan Management: Buy Rating Driven by Promising Clinical Data and Strategic Collaborations
3M ago
CGEM
Premium
Ratings
Cullinan Therapeutics: Promising Phase 2b Data and Strategic Partnerships Drive Buy Rating
3M ago
CGEM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
